Advertisement
Advertisement
MOLN
Molecular Partners AG - ADR
4.10
USDSponsored
0.00
0.00%
May 08, 16:00 UTC -4
Closed
After-Market
4.09
0.00
-0.12%
MOLN Earnings Reports
Positive Surprise Ratio
MOLN beat 4 of 4 last estimates.
100%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Molecular Partners AG - ADR earnings per share and revenue
On Mar 12, 2026, MOLN reported earnings of -0.23 USD per share (EPS) for Q4 25, beating the estimate of -0.34 USD, resulting in a 32.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.40% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
FAQ
What were Molecular Partners AG - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Molecular Partners AG - ADR reported EPS of -$0.23, beating estimates by 32.53%, and revenue of $0.00, 0% as expectations.
How did the market react to Molecular Partners AG - ADR's Q4 2025 earnings?
The stock price moved down -10.4%, changed from $4.71 before the earnings release to $4.22 the day after.
When is Molecular Partners AG - ADR expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Molecular Partners AG - ADR's next earnings report?
Based on --
analysts, Molecular Partners AG - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement